Skip to contentClarengateINTELLIGENCE
Companies/08340031

Axol Bioscience Ltd

Research and experimental development on biotechnology · Cambridge

ActiveUnited KingdomIncorporated 2012Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-12-31

IXBRL · 75 source facts · 18 selected values

Validation findings
XBRL valid
Reporting period
2025-01-01 to 2025-12-31
Extraction status
complete
Numeric facts
40
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2608_08340031_20251231
Source archive
Accounts_Monthly_Data-August2026.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2018-12-31

IXBRL · 105 source facts · 28 selected values

Not assessed
legacy record
Reporting period
2018-01-01 to 2018-12-31
Extraction status
Legacy / not assessed
Numeric facts
56
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0068_08340031_20181231
Source archive
Accounts_Monthly_Data-July2019.zip

Accounts to 2017-12-31

IXBRL · 199 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2017-01-01 to 2017-12-31
Extraction status
Legacy / not assessed
Numeric facts
136
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0057_08340031_20171231
Source archive
Accounts_Monthly_Data-August2018.zip

Accounts to 2016-12-31

IXBRL · 238 source facts · 31 selected values

Not assessed
legacy record
Reporting period
2016-01-01 to 2016-12-31
Extraction status
Legacy / not assessed
Numeric facts
166
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0043_08340031_20161231
Source archive
Accounts_Monthly_Data-June2017.zip

Accounts to 2015-12-31

IXBRL · 68 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2015-01-01 to 2015-12-31
Extraction status
Legacy / not assessed
Numeric facts
52
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0031_08340031_20151231
Source archive
Accounts_Monthly_Data-June2016.zip

Registered details

08340031
Status
Active
Type
Private Limited Company
Incorporated
2012-12-21
Jurisdiction
—
Registered office
MEDITRINA BUILDING BABRAHAM, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT, ENGLAND

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

6 matched grants
Comparative proteostasis capacity of progenitors and neurons in hiPSC motor neuron disease modelsActive
BBSRC · Studentship · 2028-09-29 – 2028-09-29 · with 1 other participant
£0
whole project
University Of CambridgeleadAxol Bioscience Ltd
A platform to investigate multi-tissue crosstalk mediated by exercise induced soluble factors released from human skeletal muscle
NC3Rs · Research Grant · 2023-02-15 – 2024-12-31 · with 1 other participant
£201,173
whole project
Loughborough UniversityleadAxol Bioscience Ltd
Modelling brain development using human induced pluripotent stem cells
BBSRC · Studentship · 2019-09-30 – 2023-12-31 · with 1 other participant
£0
whole project
University Of OxfordleadAxol Bioscience Ltd
How autophagy and related processes are coordinated and important in adaption to changed nutrient availability and cell damage
BBSRC · Institute Project · 2017-03-31 – 2024-03-31 · with 21 other participants
£6,536,205
whole project
Babraham InstituteleadAgricultural University of Athens (AUA)Amgen FoundationAxol Bioscience LtdCasma TherapeuticsEuropean CommissionFrancis Crick InstituteMedical Research Council (MRC)National University of CordobaOsaka UniversityOslo University HospitalSao Paulo State UniversityThe Pirbright InstituteUniversity Of CambridgeUniversity Of East AngliaUniversity of LeedsUniversity of LiverpoolUniversity of OsloUniversity Of OxfordUniversity Of The Highlands And IslandsUniversity of TokyoUniversity of Toronto
Development of functional purified iPSC derived astrocytes for neurological disease modelling
MRC · Studentship · 2016-09-30 – 2020-12-31 · with 1 other participant
£0
whole project
Aston UniversityleadAxol Bioscience Ltd
Generation of a site directed gene integration platform for induced pluripotent stem cell lines.
BBSRC · Research Grant · 2015-03-02 – 2016-08-31 · with 2 other participants
£134,129
whole project
Aston UniversityleadAxol Bioscience LtdUniversity of Barcelona